Showing 121 - 140 results of 929 for search '"Molecular Oncology"', query time: 0.31s Refine Results
  1. 121
    The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

    The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe by Stanislav Drápela, Prashant Khirsariya, Wytske M. vanWeerden, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Červený, Aleš Hampl, Martin Puhr, William R. Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček

    Published 2020-10-01
    “…Molecular Oncology…”
    Get full text
    Article
  2. 122
    Interferon‐regulated suprabasin is essential for stress‐induced stem‐like cell conversion and therapy resistance of human malignancies

    Interferon‐regulated suprabasin is essential for stress‐induced stem‐like cell conversion and therapy resistance of human malignancies by Sona Hubackova, Miroslav Pribyl, Lenka Kyjacova, Alena Moudra, Rastislav Dzijak, Barbora Salovska, Hynek Strnad, Vojtech Tambor, Terezie Imrichova, Jiri Svec, Pavel Vodicka, Radka Vaclavikova, Lukas Rob, Jiri Bartek, Zdenek Hodny

    Published 2019-07-01
    “…Molecular Oncology…”
    Get full text
    Article
  3. 123
    Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers

    Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers by Anna Sanchez Calle, Tomofumi Yamamoto, Yumi Kawamura, Ai Hironaka‐Mitsuhashi, Makiko Ono, Hitoshi Tsuda, Akihiko Shimomura, Kenji Tamura, Fumitaka Takeshita, Takahiro Ochiya, Yusuke Yamamoto

    Published 2020-09-01
    “…Molecular Oncology…”
    Get full text
    Article
  4. 124
    Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer

    Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer by Annette R. Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M. B. Jylling, Jeanette D. Jensen, Anne‐Vibeke Lænkholm, Ann S. Knoop, Henrik J. Ditzel

    Published 2018-06-01
    “…Molecular Oncology…”
    Get full text
    Article
  5. 125
    Extracellular vesicles and oncogenic signaling

    Extracellular vesicles and oncogenic signaling by Antonia Schubert, Michael Boutros

    Published 2021-01-01
    “…Molecular Oncology…”
    Get full text
    Article
  6. 126
    MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice

    MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice by Marie Fernandes, Brynna Hoggard, Philippe Jamme, Sonia Paget, Marie‐José Truong, Valérie Grégoire, Audrey Vinchent, Clotilde Descarpentries, Angela Morabito, Justas Stanislovas, Enoir Farage, Jean‐Pascal Meneboo, Shéhérazade Sebda, Katia Bouchekioua‐Bouzaghou, Marie Nollet, Sarah Humez, Timothy Perera, Paul Fromme, Luca Grumolato, Martin Figeac, Marie‐Christine Copin, David Tulasne, Alexis B. Cortot, Stéphanie Kermorgant, Zoulika Kherrouche

    Published 2023-11-01
    “…Molecular Oncology…”
    Get full text
    Article
  7. 127
    Integrated analysis of racial disparities in genomic architecture identifies a trans‐ancestry prognostic subtype in bladder cancer

    Integrated analysis of racial disparities in genomic architecture identifies a trans‐ancestry prognostic subtype in bladder cancer by Baifeng Zhang, Peilin Jia, Jiayin Wang, Guangsheng Pei, Changxi Wang, Shimei Pei, Xiangchun Li, Zhongming Zhao, Xin Yi, Xin‐yuan Guan, Yi Huang

    Published 2023-04-01
    “…Molecular Oncology…”
    Get full text
    Article
  8. 128
    Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network

    Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre net... by Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz‐Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Santos Vivas

    Published 2023-09-01
    “…Molecular Oncology…”
    Get full text
    Article
  9. 129
    Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition

    Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition by Kara M. Ruicci, Paul Plantinga, Nicole Pinto, Mohammed I. Khan, William Stecho, Sandeep S. Dhaliwal, John Yoo, Kevin Fung, Danielle MacNeil, Joe S. Mymryk, John W. Barrett, Christopher J. Howlett, Anthony C. Nichols

    Published 2020-01-01
    “…Molecular Oncology…”
    Get full text
    Article
  10. 130
    Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

    Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition by Cristina Andrés‐Zayas, Julia Suárez‐González, Gabriela Rodríguez‐Macías, Nieves Dorado, Santiago Osorio, Patricia Font, Diego Carbonell, María Chicano, Paula Muñiz, Mariana Bastos, Mi Kwon, José Luis Díez‐Martín, Ismael Buño, Carolina Martínez‐Laperche

    Published 2021-09-01
    “…Molecular Oncology…”
    Get full text
    Article
  11. 131
    Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma

    Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma by Silvana Debernardi, Lukasz Liszka, Chara Ntala, Katja Steiger, Irene Esposito, Emanuela Carlotti, Ann‐Marie Baker, Stuart McDonald, Trevor Graham, Branko Dmitrovic, Roger M. Feakins, Tatjana Crnogorac‐Jurcevic

    Published 2024-03-01
    “…Molecular Oncology…”
    Get full text
    Article
  12. 132
    Targeting cellular senescence to combat cancer and ageing

    Targeting cellular senescence to combat cancer and ageing by Chen Wang, Xue Hao, Rugang Zhang

    Published 2022-09-01
    “…Molecular Oncology…”
    Get full text
    Article
  13. 133
    Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a

    Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a by Taek‐Keun Kim, Chang Sik Park, Jihye Jang, Mi Ra Kim, Hee‐Jun Na, Kangseung Lee, Hyun Jung Kim, Kyun Heo, Byong Chul Yoo, Young‐Myeong Kim, Je‐Wook Lee, Su Jin Kim, Eun Sung Kim, Dae Young Kim, Kiweon Cha, Tae Gyu Lee, Sukmook Lee

    Published 2018-03-01
    “…Molecular Oncology…”
    Get full text
    Article
  14. 134
    A mission‐oriented approach to cancer in Europe: a joint mission/vision 2030

    A mission‐oriented approach to cancer in Europe: a joint mission/vision 2030 by Julio E. Celis, Dainius Pavalkis

    Published 2017-12-01
    “…Molecular Oncology…”
    Get full text
    Article
  15. 135
    Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma

    Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma by Xiaojing Du, Zhuoran Qi, Jinzhi Xu, Mengzhou Guo, Xingxing Zhang, Zhijie Yu, Xin Cao, Jinglin Xia

    Published 2022-10-01
    “…Molecular Oncology…”
    Get full text
    Article
  16. 136
    E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models

    E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical... by Jarle Bruun, Peter W. Eide, Christian Holst Bergsland, Oscar Bruck, Aud Svindland, Mariliina Arjama, Katja Välimäki, Merete Bjørnslett, Marianne G. Guren, Olli Kallioniemi, Arild Nesbakken, Ragnhild A. Lothe, Teijo Pellinen

    Published 2022-06-01
    “…Molecular Oncology…”
    Get full text
    Article
  17. 137
    Hypoxia‐sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR‐30a‐3p in non‐small cell lung cancer

    Hypoxia‐sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR‐30a‐3p in non‐small cell lung cancer by Shuai Yuan, Ying Xiang, Guilu Wang, Meiyu Zhou, Gang Meng, Qingyun Liu, Zeyao Hu, Chengying Li, Weijia Xie, Na Wu, Long Wu, Tongjian Cai, Xiangyu Ma, Yao Zhang, Zubin Yu, Li Bai, Yafei Li

    Published 2019-04-01
    “…Molecular Oncology…”
    Get full text
    Article
  18. 138
    MYC and therapy resistance in cancer: risks and opportunities

    MYC and therapy resistance in cancer: risks and opportunities by Giulio Donati, Bruno Amati

    Published 2022-11-01
    “…Molecular Oncology…”
    Get full text
    Article
  19. 139
    Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma

    Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma by Wenbin Song, Dalin He, Yule Chen, Chiuan‐Ren Yeh, Iawen Hsu, Qingbo Huang, Xu Zhang, Luke Sien‐Shih Chang, Li Zuo, Jiasheng Chen, Karen M. Doersch, Chawnshang Chang, Lei Li, Shuyuan Yeh

    Published 2018-12-01
    “…Molecular Oncology…”
    Get full text
    Article
  20. 140
    Genome‐wide DNA methylation profiling and identification of potential pan‐cancer and tumor‐specific biomarkers

    Genome‐wide DNA methylation profiling and identification of potential pan‐cancer and tumor‐specific biomarkers by Joe Ibrahim, Ken Op de Beeck, Erik Fransen, Marc Peeters, Guy Van Camp

    Published 2022-06-01
    “…Molecular Oncology…”
    Get full text
    Article

Search Tools: